Mariangela Biava

Pubblicazioni

Titolo Pubblicato in Anno
Nano-Based Drug Delivery Systems of Potent MmpL3 Inhibitors for Tuberculosis Treatment PHARMACEUTICS 2022
Malaria transmission blocking compounds: a patent review EXPERT OPINION ON THERAPEUTIC PATENTS 2022
Nano-Based Drug Delivery Systems of Potent MmpL3 Inhibitors for Tuberculosis Treatment PHARMACEUTICS 2022
Therapeutic potential for coxibs-nitric oxide releasing hybrids in cystic fibrosis EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY 2021
6-Fluorophenylbenzohydrazides inhibit Mycobacterium tuberculosis growth through alteration of tryptophan biosynthesis EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY 2021
A novel class of dual-acting DCH-CORMs counteracts oxidative stress-induced inflammation in human primary tenocytes ANTIOXIDANTS 2021
Metabolomic profiling of fresh goji (Lycium barbarum l.) berries from two cultivars grown in central italy: A multi-methodological approach MOLECULES 2021
Dietary flavonoids: Nano delivery and nanoparticles for cancer therapy SEMINARS IN CANCER BIOLOGY 2020
Sar analysis of small molecules interfering with energy-metabolism in mycobacterium tuberculosis PHARMACEUTICALS 2020
Overcoming drug resistance in TB: An update FUTURE MICROBIOLOGY 2020
Neutrophil-to-lymphocyte ratio, mediterranean diet, and bone health in coeliac disease patients: a pilot Study OXIDATIVE MEDICINE AND CELLULAR LONGEVITY 2019
Mycobacterial tryptophan biosynthesis: a promising target for tuberculosis drug development? BIOORGANIC & MEDICINAL CHEMISTRY LETTERS 2019
Novel pyrazole-containing compounds active against mycobacterium tuberculosis ACS MEDICINAL CHEMISTRY LETTERS 2019
Chocolate consumers and lymphocyte-to-monocyte ratio: a working hypothesis from a preliminary report of a pilot study in celiac subjects ANTIOXIDANTS 2019
Development of MmpL3 inhibitors for tuberculosis treatment Medicinal Chemistry approaches to tuberculosis and trypanosomiasis 2019
In vivo potent BM635 analogue with improved drug-like properties EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY 2018
Introduction to COX inhibitors FUTURE MEDICINAL CHEMISTRY 2018
In vitro comprehensive analysis of VA692 a new chemical entity for the treatment of osteoarthritis INTERNATIONAL IMMUNOPHARMACOLOGY 2018
1,5-Diarylpyrroles as potent antitubercular and anti-inflammatory agents CHEMISTRY OF HETEROCYCLIC COMPOUNDS 2017
Pharmaceutical salt of BM635 with improved bioavailability EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES 2017

Progetti di Ricerca

© Università degli Studi di Roma "La Sapienza" - Piazzale Aldo Moro 5, 00185 Roma